Investigational Drug Information for Adavosertib
✉ Email this page to a colleague
What is the development status for investigational drug Adavosertib?
Adavosertib is an investigational drug.
There have been 29 clinical trials for Adavosertib.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 30th 2015.
The most common disease conditions in clinical trials are Neoplasms, Carcinoma, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), AstraZeneca, and Parexel.
There are twenty-four US patents protecting this investigational drug and three hundred and nine international patents.
Summary for Adavosertib
| US Patents | 24 |
| International Patents | 309 |
| US Patent Applications | 159 |
| WIPO Patent Applications | 145 |
| Japanese Patent Applications | 15 |
| Clinical Trial Progress | Phase 1 (2015-01-30) |
| Vendors | 63 |
Recent Clinical Trials for Adavosertib
| Title | Sponsor | Phase |
|---|---|---|
| Adavosertib and Gemcitabine in Advanced Pancreatic | AstraZeneca | Phase 2 |
| Adavosertib and Gemcitabine in Advanced Pancreatic | Lustgarten Foundation | Phase 2 |
| Adavosertib and Gemcitabine in Advanced Pancreatic | Stand Up To Cancer | Phase 2 |
Clinical Trial Summary for Adavosertib
Top disease conditions for Adavosertib
Top clinical trial sponsors for Adavosertib
US Patents for Adavosertib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Adavosertib | ⤷ Sign Up | Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids | Cantex Pharmaceuticals, Inc. (Weston, FL) | ⤷ Sign Up |
| Adavosertib | ⤷ Sign Up | Silanol based therapeutic payloads | BlinkBio, Inc. (Jupiter, FL) | ⤷ Sign Up |
| Adavosertib | ⤷ Sign Up | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| Adavosertib | ⤷ Sign Up | Methods and compositions for treatment of cancer and autoimmune disease | THE JACKSON LABORATORY (Bar Harbor, ME) | ⤷ Sign Up |
| Adavosertib | ⤷ Sign Up | Silanol based therapeutic payloads | BlinkBio, Inc. (Jupiter, FL) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Adavosertib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Adavosertib | European Patent Office | EP3258941 | 2035-02-17 | ⤷ Sign Up |
| Adavosertib | World Intellectual Property Organization (WIPO) | WO2016133910 | 2035-02-17 | ⤷ Sign Up |
| Adavosertib | Australia | AU2017277949 | 2036-06-09 | ⤷ Sign Up |
| Adavosertib | Canada | CA3026651 | 2036-06-09 | ⤷ Sign Up |
| Adavosertib | China | CN109475567 | 2036-06-09 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
